Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after BioMarin BMRN agreed to ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Tourmaline Bio is well-funded, with cash runway into 2H 2027, minimizing near-term dilution risk for investors. Click here to ...

The global Burn Care Market is projected to be valued at USD 2.79 billion in 2024 and reach US$ 4.23 billion by 2030, growing ...

Shares of biotechnology company Prime Medicine, Inc. (PRME) fell 18% on Monday afternoon after the company announced a ...

T he cost of prescription drugs in the U.S. has long outpaced that of peer nations, a dynamic driven by a combination of ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

the biotech company Centivax developed full protection against 13 snake species and partial protection for a further six. The team hopes to develop treatment for viper snake bites, and will soon ...

This will open doors for new advances in medicine, agriculture, and biotechnology by helping scientists design proteins that can multitask more efficiently. “Two structurally identical plant ...

Of course, biotechnology also promises to change the world by transforming medicine, and this is another sector where the UK is among the global leaders. Indeed Cambridge, known as the UK’s ...

Global and US biotech shares have recovered from their ... Overall survival is how long a patient lives from the time of diagnosis or treatment until their death, regardless of the cause.